ATHE
Price
$2.75
Change
-$0.15 (-5.17%)
Updated
Apr 7, 04:57 PM (EDT)
Capitalization
27.1M
GLMD
Price
$1.24
Change
-$0.10 (-7.46%)
Updated
Apr 7, 04:55 PM (EDT)
Capitalization
2.8M
29 days until earnings call
Ad is loading...

ATHE vs GLMD

Header iconATHE vs GLMD Comparison
Open Charts ATHE vs GLMDBanner chart's image
Alterity Therapeutics
Price$2.75
Change-$0.15 (-5.17%)
Volume$775
Capitalization27.1M
Galmed Pharmaceuticals
Price$1.24
Change-$0.10 (-7.46%)
Volume$2.2K
Capitalization2.8M
ATHE vs GLMD Comparison Chart
Loading...
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATHE vs. GLMD commentary
Apr 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHE is a Hold and GLMD is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 08, 2025
Stock price -- (ATHE: $2.90 vs. GLMD: $1.34)
Brand notoriety: ATHE and GLMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHE: 9% vs. GLMD: 7%
Market capitalization -- ATHE: $27.1M vs. GLMD: $2.8M
ATHE [@Biotechnology] is valued at $27.1M. GLMD’s [@Biotechnology] market capitalization is $2.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHE’s FA Score shows that 0 FA rating(s) are green whileGLMD’s FA Score has 0 green FA rating(s).

  • ATHE’s FA Score: 0 green, 5 red.
  • GLMD’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATHE and GLMD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLMD’s TA Score shows that 3 TA indicator(s) are bullish.

  • GLMD’s TA Score: 3 bullish, 5 bearish.

Price Growth

ATHE (@Biotechnology) experienced а -15.70% price change this week, while GLMD (@Biotechnology) price change was -15.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.12%. For the same industry, the average monthly price growth was -17.78%, and the average quarterly price growth was -18.34%.

Reported Earning Dates

ATHE is expected to report earnings on May 31, 2023.

GLMD is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-9.12% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATHE($27.1M) has a higher market cap than GLMD($2.8M). ATHE YTD gains are higher at: -12.387 vs. GLMD (-57.994). GLMD has higher annual earnings (EBITDA): -6.7M vs. ATHE (-19.88M). GLMD has more cash in the bank: 17.1M vs. ATHE (4.54M). GLMD has less debt than ATHE: GLMD (41K) vs ATHE (106K). ATHE (0) and GLMD (0) have equivalent revenues.
ATHEGLMDATHE / GLMD
Capitalization27.1M2.8M968%
EBITDA-19.88M-6.7M297%
Gain YTD-12.387-57.99421%
P/E RatioN/A0.02-
Revenue00-
Total Cash4.54M17.1M27%
Total Debt106K41K259%
FUNDAMENTALS RATINGS
ATHE vs GLMD: Fundamental Ratings
ATHE
GLMD
OUTLOOK RATING
1..100
5696
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
42
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
3796
P/E GROWTH RATING
1..100
10095
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GLMD's Valuation (42) in the Pharmaceuticals Other industry is somewhat better than the same rating for ATHE (88) in the Biotechnology industry. This means that GLMD’s stock grew somewhat faster than ATHE’s over the last 12 months.

GLMD's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ATHE (100) in the Biotechnology industry. This means that GLMD’s stock grew similarly to ATHE’s over the last 12 months.

GLMD's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as ATHE (100) in the Biotechnology industry. This means that GLMD’s stock grew similarly to ATHE’s over the last 12 months.

ATHE's Price Growth Rating (37) in the Biotechnology industry is somewhat better than the same rating for GLMD (96) in the Pharmaceuticals Other industry. This means that ATHE’s stock grew somewhat faster than GLMD’s over the last 12 months.

GLMD's P/E Growth Rating (95) in the Pharmaceuticals Other industry is in the same range as ATHE (100) in the Biotechnology industry. This means that GLMD’s stock grew similarly to ATHE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLMD
RSI
ODDS (%)
Bullish Trend 7 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
86%
Momentum
ODDS (%)
Bearish Trend 7 days ago
90%
MACD
ODDS (%)
Bearish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
90%
Advances
ODDS (%)
Bullish Trend 22 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
85%
Aroon
ODDS (%)
Bearish Trend 7 days ago
90%
View a ticker or compare two or three
Ad is loading...
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.492.39
+11.33%
GameStop Corp
SPY505.28-31.42
-5.85%
SPDR® S&P 500® ETF Trust
BTC.X78214.484000-5290.312500
-6.34%
Bitcoin cryptocurrency
AAPL188.38-14.81
-7.29%
Apple
TSLA239.43-27.85
-10.42%
Tesla

ATHE and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHE has been loosely correlated with EYPT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHE jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHE
1D Price
Change %
ATHE100%
-1.12%
EYPT - ATHE
54%
Loosely correlated
-7.62%
GLMD - ATHE
31%
Poorly correlated
-8.22%
CVM - ATHE
30%
Poorly correlated
+8.65%
SEPSF - ATHE
29%
Poorly correlated
N/A
MSCLF - ATHE
28%
Poorly correlated
-2.07%
More

GLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLMD has been loosely correlated with HXBM. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if GLMD jumps, then HXBM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLMD
1D Price
Change %
GLMD100%
-8.22%
HXBM - GLMD
38%
Loosely correlated
N/A
IOBT - GLMD
35%
Loosely correlated
-2.07%
REVB - GLMD
31%
Poorly correlated
-4.63%
ATHE - GLMD
30%
Poorly correlated
-1.12%
RARE - GLMD
30%
Poorly correlated
-7.69%
More